PDF
Kurs
-12,69%
Likviditet
0,49 MSEK
Kalender
| Est. tid* | ||
| 2026-02-12 | 08:30 | Bokslutskommuniké 2025 |
| 2025-11-05 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-21 | N/A | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2025-05-20 | N/A | Årsstämma |
| 2025-05-06 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-19 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-16 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2024-05-15 | - | Årsstämma |
| 2024-04-30 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-09 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-19 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2023-05-17 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-17 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-19 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2022-05-17 | - | Årsstämma |
| 2022-05-04 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-18 | - | Bokslutskommuniké 2021 |
| 2022-01-12 | - | Extra Bolagsstämma 2021 |
| 2021-11-16 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-18 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2021-05-17 | - | Årsstämma |
| 2021-05-05 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-08 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2020-05-07 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-18 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-17 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2019-05-16 | - | Årsstämma |
| 2019-05-09 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-20 | - | Bokslutskommuniké 2018 |
| 2018-11-08 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-16 | - | Årsstämma |
| 2018-05-09 | - | Kvartalsrapport 2018-Q1 |
| 2018-05-04 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2018-05-03 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-09 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-31 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2017-05-30 | - | Årsstämma |
| 2017-05-10 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-22 | - | Bokslutskommuniké 2016 |
| 2016-12-19 | - | Extra Bolagsstämma 2016 |
| 2016-11-11 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-11 | - | X-dag ordinarie utdelning ORGC 0.00 SEK |
| 2016-05-10 | - | Årsstämma |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-24 | - | Bokslutskommuniké 2015 |
| 2015-11-11 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-21 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-26 | - | Kvartalsrapport 2015-Q1 |
| 2015-05-05 | - | Årsstämma |
| 2015-03-31 | - | Bokslutskommuniké 2014 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Material |
| Industri | Forskning & Utveckling |
"2024 has been a challenging year but with big differences between our business units. Our consumer products showed good growth and our own brands, OrganoTex and BIOkleen, grew by more than 30 percent while our industrial products had tougher market conditions. In the fourth quarter we saw the same trend as earlier in the year. Our consumer products experienced growth, while our industrial products continued to show negative growth. Total sales amounted to MSEK 21.4 (27.9), a decrease of -23 (29) percent. However, our operating profit decreased only marginally to MSEK -6.9 (-6.1) thanks to good cost control. Sales for 2024 decreased by a total of -13 (27) percent to MSEK 127.2 (145.9), while the operating loss was MSEK -9.9 (-9.2). By contrast, cash flow from operating activities strengthened substantially to MSEK 3.6 (0.5) thanks to inventory reductions."
Translation from CEO Mårten Hellbergs comments to the Interim Report.
Q4, 1 October - 31 December 2024
The Group's result in Q4 2024 compared with Q4 2023
» Net revenue amounted to SEK 21.43 (27.91) million
» The gross margin amounted to 12.7 (18.4) %
» EBIT amounted to SEK -6.88 (-6.13) million
» Cash-flow from operating activities amounted to SEK 4.70 (6.66) million
1 January - 31 December 2024
The Group compared with 2023
» Net revenue amounted to SEK 127.23 (145.87) million
» The gross margin amounted to 25.0 (24.3) %
» EBIT amounted to SEK -9.86 (-9.23) million
» Cash-flow from operating activities amounted to SEK 3.60 (0.53) million
This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 13-02-2025 08:30 CET.
.........................................................................................
For more information, please contact:
Mårten Hellberg, CEO
0707 - 16 48 90, marten.hellberg@organoclick.com